Catalyst Wire Dossier Catalyst Wire Dossier

Alna Ocas

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alna Ocas, covering 2014-09-19 to 2014-09-19. Get the full timeline:

Most recent: Clinical Trial Update: The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

See pricing